Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / January / Asymptomatic Meibomian Gland Characteristics
Anterior Segment News Research & Innovations

Asymptomatic Meibomian Gland Characteristics 

Silent gland failure: what do asymptomatic adults reveal about subclinical MGD?

1/14/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Quiz
  • Poll
  • Top Institutions
Objective:

To investigate the prevalence of meibomian gland abnormalities in asymptomatic adults and assess the implications for Meibomian gland dysfunction (MGD).

Key Findings:
  • 71% of upper eyelids and 51% of lower eyelids showed meiboscore ≥1, indicating gland dropout.
  • Telangiectasia present in 82% and gland plugging in 84% of subjects.
  • Median FTBUT was 5.04 seconds, with no significant age-related differences.
  • Lipid layer thickness (LLT) averaged 61 ± 20 μm, within healthy ranges.
  • Schirmer I test indicated significant age-related differences in tear function.
Interpretation:

The study suggests that asymptomatic individuals may already be experiencing early stages of MGD, highlighting the need for proactive screening and potential early intervention.

Limitations:
  • Small sample size of 60 participants.
  • Cross-sectional design limits causal inferences.
Conclusion:

Asymptomatic individuals may have significant meibomian gland abnormalities, indicating that absence of symptoms does not equate to absence of disease. Early detection and intervention could alter the progression of dry eye disease.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: